DexCom, Inc. 8-K Report: Key Updates for Shareholders on March 6, 2025

Here’s the key information extracted from the provided section of the financial report:

1. Filing Type: 8-K

• This indicates that the report is a current report used to announce major events that shareholders should know about.

2. Company Information:

• Name: DexCom, Inc.
• State of Incorporation: Delaware (DE)
• SEC Central Index Key (CIK): 0001093557
• Tax Identification Number (EIN): 33-0857544
• Address: 6340 Sequence Drive, San Diego, CA 92121
• Phone Number: 858-200-0200

3. Stock Information:

• Common Stock: $0.001 Par Value Per Share
• Stock Symbol: DXCM
• Exchange: NASDAQ

4. Report Date:

• Filing Date: March 6, 2025
• Period Covered: The report is for a single day, March 6, 2025.

5. XML Metadata:

• The report uses XBRL (eXtensible Business Reporting Language), which is a standard for digital business reporting.

Insights:

• The filing of an 8-K suggests that DexCom, Inc. has experienced a significant event that necessitates disclosure to investors.
• The date of the report indicates it is a future filing, suggesting potential events or changes that are planned or anticipated.
• DexCom is listed on NASDAQ, which could be relevant for investors considering the company's stock performance and market activity.

Overall, the information presented indicates a formal communication from DexCom, Inc. to its shareholders, which could include updates about business operations, financial performance, or other material changes affecting the company. Further context regarding the specifics of the event would be necessary for deeper analysis.